Current Report Filing (8-k)
May 14 2020 - 7:53AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 14, 2020
JRSIS
HEALTH CARE CORPORATION
(Exact
name of registrant as specified in its charter)
Florida
|
|
1-36758
|
|
46-4562047
|
(State or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer
|
of Incorporation)
|
|
File Number)
|
|
Identification No.)
|
No.
38 South Street, Hulan District, Harbin City
Heilongjiang
Province, P.R. China 150025
(Address
of Principal Executive Office) (Zip Code)
86-451-56888933
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
|
|
|
|
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
8.01 Other Events.
On
March 4, 2020, pursuant to Section 36 of the Securities Exchange Act of 1934, the Securities and Exchange Commission issued Release
No. 34-88318 (the “Order”) granting exemptions to registrants subject to the reporting requirements of the Exchange
Act Section 13(a) or 15(d) due to circumstances related to the coronavirus disease 2019 (COVID-19).
JRSIS
Health Care Corporation is furnishing this Current Report on Form 8-K to indicate its reliance on the Order in connection with
the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2019.
The
Company’s headquarters and operations are located in the City of Harbin, China. Due to the ongoing outbreak of the COVID-19,
the Chinese government initiated travel restrictions and mandatory quarantines to control the spread of COVID-19 within China.
These actions taken by the Chinese government have prevented the Company’s accounting department from completing the financial
data and related materials necessary for the first quarter financial statements to be completed in a timely manner. As a result,
the Company will be unable to file the Form 10-Q by May 15, 2020.
The Company
expects to file its Quarterly Report on Form 10-Q within 45 days after May 15, 2020.
The
Company is also publishing the following Risk Factor:
The
spread of COVID-19 through the population of the City of Harbin and the mandatory quarantines imposed by the government to stop
the spread have significantly interfered with the business of Jiarun Hospital, which will have a significant adverse effect on
our income and profitability.
The
Company’s only business activity is ownership and operation of Jiarun Hospital (including its two satellites), the largest hospital
in the City of Harbin. Many residents of Harbin have contracted COVID-19 during the current pandemic. As a result, the national
and local government have imposed serious restrictions on business operations within the City, including mandatory quarantines.
The quarantines have prevented Jiarun Hospital from carrying on its normal operations. As a result, the Company’s revenue and
income for the first six months of 2020 will be substantially lower than were reported for the first six months of 2019.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
JRSIS Health Care Corporation
|
|
|
|
Date:
May 14, 2020
|
By:
|
/s/
Lihua Sun
|
|
|
Lihua
Sun,
Chief Executive Officer
|
2
JRSIS Health Care (PK) (USOTC:JRSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
JRSIS Health Care (PK) (USOTC:JRSS)
Historical Stock Chart
From Apr 2023 to Apr 2024